Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower MED Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Resilience SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback CBFV Q1 2026 Earnings EPS Beats Estimates Stock Rises on Strong Performance Metallus MTUS Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Headwinds Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues